REVLIMID

Generic: LENALIDOMIDE

Manufacturer: Celgene Corporation

Thalidomide Analog [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Proteasome Inhibitor [EPC]
409,021
Total Reports
159,410
Serious Reports
52,907
Death Reports
30
Reported Reactions
Death Report Ratio: High (12.94%)

Patient Demographics

Male
202,496
Female
190,984

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for REVLIMID.

# Reaction Reports % of Total
1 DIARRHOEA 30,626
9.0%
2 DEATH 26,188
7.7%
3 FATIGUE 26,152
7.7%
4 PNEUMONIA 18,404
5.4%
5 OFF LABEL USE 18,216
5.4%
6 RASH 17,714
5.2%
7 PLASMA CELL MYELOMA 16,822
5.0%
8 NEUROPATHY PERIPHERAL 11,857
3.5%
9 WHITE BLOOD CELL COUNT DECREASED 11,645
3.4%
10 CONSTIPATION 10,846
3.2%
11 NAUSEA 10,623
3.1%
12 ASTHENIA 9,909
2.9%
13 PLATELET COUNT DECREASED 9,428
2.8%
14 NEUTROPENIA 8,929
2.6%
15 PRODUCT DOSE OMISSION ISSUE 8,592
2.5%
16 MUSCLE SPASMS 7,568
2.2%
17 DYSPNOEA 7,527
2.2%
18 THROMBOSIS 7,453
2.2%
19 FALL 7,336
2.2%
20 ANAEMIA 7,331
2.2%
21 PRURITUS 7,197
2.1%
22 DIZZINESS 7,112
2.1%
23 PYREXIA 7,096
2.1%
24 FULL BLOOD COUNT DECREASED 7,025
2.1%
25 PERIPHERAL SWELLING 6,619
2.0%
26 COVID-19 6,478
1.9%
27 THROMBOCYTOPENIA 6,429
1.9%
28 DRUG INEFFECTIVE 6,391
1.9%
29 PAIN 5,958
1.8%
30 DECREASED APPETITE 5,936
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.